Literature DB >> 2616134

Grating acuity overestimates Snellen acuity in patients with age-related maculopathy.

J M White1, D S Loshin.   

Abstract

In foveally fixating patients resolution acuity is approximately the same when measured with a Snellen chart (Snellen acuity) or when estimated from the high frequency cutoff of the contrast sensitivity function (CSF) (grating acuity). In contrast, with peripheral viewing, normal patients have better grating than Snellen acuity. This suggests that grating acuity deteriorates less rapidly with eccentricity than does Snellen acuity. If patients with bilateral age-related maculopathy (ARM) fixate with a single, healthy peripheral-retinal locus, grating and Snellen acuities should be similar to those in the normal periphery. As expected from the normal data, grating acuity was better than Snellen acuity in all 19 patients with ARM. Although some showed acuities which were similar to those of the normal periphery, others had Snellen acuities that were even worse than predicted from the normal peripheral acuity. Possible explanations for the superiority of grating over Snellen acuity are discussed.

Entities:  

Mesh:

Year:  1989        PMID: 2616134     DOI: 10.1097/00006324-198911000-00005

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  3 in total

1.  A comparison of contrast sensitivity and sweep visual evoked potential (sVEP) acuity estimates in normal humans.

Authors:  William H Ridder
Journal:  Doc Ophthalmol       Date:  2019-08-14       Impact factor: 2.379

2.  Grating visual acuity results in the early treatment for retinopathy of prematurity study.

Authors:  Velma Dobson; Graham E Quinn; C Gail Summers; Robert J Hardy; Betty Tung; William V Good
Journal:  Arch Ophthalmol       Date:  2011-07

3.  Sex & vision I: Spatio-temporal resolution.

Authors:  Israel Abramov; James Gordon; Olga Feldman; Alla Chavarga
Journal:  Biol Sex Differ       Date:  2012-09-04       Impact factor: 5.027

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.